AFYREN (Paris:ALAFY), a greentech company that offers manufacturers bio-based, low-carbon ingredients produced using unique fermentation technology based on a completely circular model, has signed a commercial contract with a US nutraceutical ingredients manufacturer.
AFYREN has signed a new multi-year contract with a US-based company specialized in nutraceuticals ingredients and solutions, a high added value fast-growing market where food meets pharma. Under the multi-year contract, AFYREN will provide its bio-based acids to the client, a provider of ingredients and solutions, for applications such as preservatives and flavors for nutritional supplements. The multi-billion-dollar nutraceuticals market is expected to grow in the high-single digits over the next years, driven by consumer appetite for products that can improve their overall health and well-being, with a focus on natural and sustainable ingredients1.
The client, a renowned player in this space, had been unsuccessfully looking for alternatives to petro-based solutions. The nature of AFYREN’s process — based on natural fermentation of non-food feedstock — and the ability to trace the origin of the acids were instrumental in the client’s decision to use AFYREN’s products.
Initially based on limited volumes, this contract could evolve towards more significant quantities.
“We and our client share the same mindset and ambition to provide quality and sustainable solutions, based on traceable value chains. This new contract shows our capacity to address more specific markets – in addition to our current client base in large established markets – with a value proposition that is not met by existing solutions. Naturality is indeed a secular growth driver for our food and pharma markets, both in volume and value”, declared Nicolas Sordet, CEO of AFYREN.
